nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP1A2—Estropipate—osteoporosis	0.0707	0.11	CbGbCtD
Almotriptan—CYP2C8—Raloxifene—osteoporosis	0.0609	0.0947	CbGbCtD
Almotriptan—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0589	0.0914	CbGbCtD
Almotriptan—CYP2C8—Cholecalciferol—osteoporosis	0.0471	0.0731	CbGbCtD
Almotriptan—CYP2C19—Cholecalciferol—osteoporosis	0.0395	0.0613	CbGbCtD
Almotriptan—CYP2C8—Estradiol—osteoporosis	0.0379	0.0589	CbGbCtD
Almotriptan—CYP3A4—Calcitriol—osteoporosis	0.037	0.0575	CbGbCtD
Almotriptan—CYP3A4—Estropipate—osteoporosis	0.037	0.0575	CbGbCtD
Almotriptan—CYP1A2—Conjugated Estrogens—osteoporosis	0.0334	0.0519	CbGbCtD
Almotriptan—CYP2C19—Estradiol—osteoporosis	0.0318	0.0494	CbGbCtD
Almotriptan—CYP2D6—Cholecalciferol—osteoporosis	0.03	0.0466	CbGbCtD
Almotriptan—CYP3A4—Ergocalciferol—osteoporosis	0.0296	0.046	CbGbCtD
Almotriptan—CYP1A2—Estradiol—osteoporosis	0.0294	0.0456	CbGbCtD
Almotriptan—CYP3A4—Raloxifene—osteoporosis	0.0247	0.0384	CbGbCtD
Almotriptan—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0239	0.0371	CbGbCtD
Almotriptan—CYP3A4—Cholecalciferol—osteoporosis	0.0191	0.0296	CbGbCtD
Almotriptan—CYP3A4—Conjugated Estrogens—osteoporosis	0.0175	0.0272	CbGbCtD
Almotriptan—CYP3A4—Estradiol—osteoporosis	0.0154	0.0239	CbGbCtD
Almotriptan—Melatonin—CYP19A1—osteoporosis	0.00111	0.521	CrCbGaD
Almotriptan—Melatonin—ESR1—osteoporosis	0.00102	0.479	CrCbGaD
Almotriptan—Hypersensitivity—Estropipate—osteoporosis	0.000337	0.00105	CcSEcCtD
Almotriptan—Nervous system disorder—Pamidronate—osteoporosis	0.000337	0.00105	CcSEcCtD
Almotriptan—Vomiting—Etidronic acid—osteoporosis	0.000337	0.00105	CcSEcCtD
Almotriptan—Tachycardia—Pamidronate—osteoporosis	0.000336	0.00105	CcSEcCtD
Almotriptan—Rash—Etidronic acid—osteoporosis	0.000334	0.00104	CcSEcCtD
Almotriptan—Convulsion—Zoledronate—osteoporosis	0.000334	0.00104	CcSEcCtD
Almotriptan—Dermatitis—Etidronic acid—osteoporosis	0.000333	0.00104	CcSEcCtD
Almotriptan—Vertigo—Conjugated Estrogens—osteoporosis	0.000333	0.00104	CcSEcCtD
Almotriptan—Hyperhidrosis—Pamidronate—osteoporosis	0.000333	0.00104	CcSEcCtD
Almotriptan—Syncope—Conjugated Estrogens—osteoporosis	0.000332	0.00104	CcSEcCtD
Almotriptan—Hypertension—Zoledronate—osteoporosis	0.000332	0.00104	CcSEcCtD
Almotriptan—Hypersensitivity—Alendronate—osteoporosis	0.000332	0.00104	CcSEcCtD
Almotriptan—Headache—Etidronic acid—osteoporosis	0.000332	0.00104	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00033	0.00103	CcSEcCtD
Almotriptan—Asthenia—Estropipate—osteoporosis	0.000329	0.00103	CcSEcCtD
Almotriptan—Visual impairment—Estradiol—osteoporosis	0.000329	0.00103	CcSEcCtD
Almotriptan—Chest pain—Zoledronate—osteoporosis	0.000328	0.00102	CcSEcCtD
Almotriptan—Arthralgia—Zoledronate—osteoporosis	0.000328	0.00102	CcSEcCtD
Almotriptan—Myalgia—Zoledronate—osteoporosis	0.000328	0.00102	CcSEcCtD
Almotriptan—Palpitations—Conjugated Estrogens—osteoporosis	0.000328	0.00102	CcSEcCtD
Almotriptan—Insomnia—Risedronate—osteoporosis	0.000327	0.00102	CcSEcCtD
Almotriptan—Anxiety—Zoledronate—osteoporosis	0.000327	0.00102	CcSEcCtD
Almotriptan—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000326	0.00102	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000326	0.00102	CcSEcCtD
Almotriptan—Paraesthesia—Risedronate—osteoporosis	0.000325	0.00102	CcSEcCtD
Almotriptan—Pruritus—Estropipate—osteoporosis	0.000324	0.00101	CcSEcCtD
Almotriptan—Discomfort—Zoledronate—osteoporosis	0.000324	0.00101	CcSEcCtD
Almotriptan—Asthenia—Alendronate—osteoporosis	0.000324	0.00101	CcSEcCtD
Almotriptan—Hypersensitivity—Ibandronate—osteoporosis	0.000324	0.00101	CcSEcCtD
Almotriptan—Dyspnoea—Risedronate—osteoporosis	0.000323	0.00101	CcSEcCtD
Almotriptan—Convulsion—Conjugated Estrogens—osteoporosis	0.000321	0.001	CcSEcCtD
Almotriptan—Dry mouth—Zoledronate—osteoporosis	0.000321	0.001	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00032	0.001	CcSEcCtD
Almotriptan—Fatigue—Ethinyl Estradiol—osteoporosis	0.00032	0.001	CcSEcCtD
Almotriptan—Pruritus—Alendronate—osteoporosis	0.000319	0.000997	CcSEcCtD
Almotriptan—Dyspepsia—Risedronate—osteoporosis	0.000319	0.000995	CcSEcCtD
Almotriptan—Eye disorder—Estradiol—osteoporosis	0.000319	0.000995	CcSEcCtD
Almotriptan—Tinnitus—Estradiol—osteoporosis	0.000318	0.000993	CcSEcCtD
Almotriptan—Confusional state—Zoledronate—osteoporosis	0.000317	0.00099	CcSEcCtD
Almotriptan—Hypersensitivity—Calcitriol—osteoporosis	0.000317	0.000989	CcSEcCtD
Almotriptan—Cardiac disorder—Estradiol—osteoporosis	0.000316	0.000988	CcSEcCtD
Almotriptan—Chest pain—Conjugated Estrogens—osteoporosis	0.000316	0.000986	CcSEcCtD
Almotriptan—Arthralgia—Conjugated Estrogens—osteoporosis	0.000316	0.000986	CcSEcCtD
Almotriptan—Myalgia—Conjugated Estrogens—osteoporosis	0.000316	0.000986	CcSEcCtD
Almotriptan—Asthenia—Ibandronate—osteoporosis	0.000315	0.000984	CcSEcCtD
Almotriptan—Anxiety—Conjugated Estrogens—osteoporosis	0.000315	0.000983	CcSEcCtD
Almotriptan—Nausea—Etidronic acid—osteoporosis	0.000314	0.000982	CcSEcCtD
Almotriptan—Anaphylactic shock—Zoledronate—osteoporosis	0.000314	0.000982	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000313	0.000979	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000313	0.000979	CcSEcCtD
Almotriptan—Diarrhoea—Estropipate—osteoporosis	0.000313	0.000979	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Risedronate—osteoporosis	0.000312	0.000976	CcSEcCtD
Almotriptan—Fatigue—Risedronate—osteoporosis	0.000312	0.000975	CcSEcCtD
Almotriptan—Insomnia—Pamidronate—osteoporosis	0.000311	0.000972	CcSEcCtD
Almotriptan—Pruritus—Ibandronate—osteoporosis	0.000311	0.000971	CcSEcCtD
Almotriptan—Pain—Risedronate—osteoporosis	0.000309	0.000967	CcSEcCtD
Almotriptan—Shock—Zoledronate—osteoporosis	0.000309	0.000966	CcSEcCtD
Almotriptan—Paraesthesia—Pamidronate—osteoporosis	0.000309	0.000965	CcSEcCtD
Almotriptan—Diarrhoea—Alendronate—osteoporosis	0.000309	0.000964	CcSEcCtD
Almotriptan—Asthenia—Calcitriol—osteoporosis	0.000308	0.000963	CcSEcCtD
Almotriptan—Nervous system disorder—Zoledronate—osteoporosis	0.000308	0.000963	CcSEcCtD
Almotriptan—Immune system disorder—Estradiol—osteoporosis	0.000308	0.000962	CcSEcCtD
Almotriptan—Dyspnoea—Pamidronate—osteoporosis	0.000307	0.000958	CcSEcCtD
Almotriptan—Tachycardia—Zoledronate—osteoporosis	0.000307	0.000958	CcSEcCtD
Almotriptan—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000306	0.000955	CcSEcCtD
Almotriptan—Chills—Estradiol—osteoporosis	0.000306	0.000955	CcSEcCtD
Almotriptan—Somnolence—Pamidronate—osteoporosis	0.000306	0.000955	CcSEcCtD
Almotriptan—Skin disorder—Zoledronate—osteoporosis	0.000305	0.000953	CcSEcCtD
Almotriptan—Pruritus—Calcitriol—osteoporosis	0.000304	0.00095	CcSEcCtD
Almotriptan—Hyperhidrosis—Zoledronate—osteoporosis	0.000304	0.000949	CcSEcCtD
Almotriptan—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000304	0.000948	CcSEcCtD
Almotriptan—Diarrhoea—Raloxifene—osteoporosis	0.000304	0.000948	CcSEcCtD
Almotriptan—Dyspepsia—Pamidronate—osteoporosis	0.000303	0.000946	CcSEcCtD
Almotriptan—Dizziness—Estropipate—osteoporosis	0.000303	0.000946	CcSEcCtD
Almotriptan—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000303	0.000945	CcSEcCtD
Almotriptan—Diarrhoea—Ibandronate—osteoporosis	0.0003	0.000939	CcSEcCtD
Almotriptan—Mental disorder—Estradiol—osteoporosis	0.000299	0.000933	CcSEcCtD
Almotriptan—Dizziness—Alendronate—osteoporosis	0.000298	0.000932	CcSEcCtD
Almotriptan—Shock—Conjugated Estrogens—osteoporosis	0.000298	0.00093	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000297	0.000928	CcSEcCtD
Almotriptan—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000297	0.000927	CcSEcCtD
Almotriptan—Erythema—Estradiol—osteoporosis	0.000297	0.000927	CcSEcCtD
Almotriptan—Fatigue—Pamidronate—osteoporosis	0.000297	0.000927	CcSEcCtD
Almotriptan—Gastrointestinal pain—Risedronate—osteoporosis	0.000296	0.000924	CcSEcCtD
Almotriptan—Tachycardia—Conjugated Estrogens—osteoporosis	0.000295	0.000922	CcSEcCtD
Almotriptan—Pain—Pamidronate—osteoporosis	0.000294	0.000919	CcSEcCtD
Almotriptan—Diarrhoea—Calcitriol—osteoporosis	0.000294	0.000919	CcSEcCtD
Almotriptan—Skin disorder—Conjugated Estrogens—osteoporosis	0.000294	0.000918	CcSEcCtD
Almotriptan—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000293	0.000917	CcSEcCtD
Almotriptan—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000293	0.000917	CcSEcCtD
Almotriptan—Dizziness—Raloxifene—osteoporosis	0.000293	0.000916	CcSEcCtD
Almotriptan—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000293	0.000914	CcSEcCtD
Almotriptan—Tension—Estradiol—osteoporosis	0.000291	0.00091	CcSEcCtD
Almotriptan—Vomiting—Estropipate—osteoporosis	0.000291	0.00091	CcSEcCtD
Almotriptan—Dysgeusia—Estradiol—osteoporosis	0.000291	0.000908	CcSEcCtD
Almotriptan—Dizziness—Ibandronate—osteoporosis	0.00029	0.000907	CcSEcCtD
Almotriptan—Rash—Estropipate—osteoporosis	0.000289	0.000902	CcSEcCtD
Almotriptan—Dermatitis—Estropipate—osteoporosis	0.000288	0.000901	CcSEcCtD
Almotriptan—Nervousness—Estradiol—osteoporosis	0.000288	0.0009	CcSEcCtD
Almotriptan—Back pain—Estradiol—osteoporosis	0.000287	0.000897	CcSEcCtD
Almotriptan—Headache—Estropipate—osteoporosis	0.000287	0.000896	CcSEcCtD
Almotriptan—Vomiting—Alendronate—osteoporosis	0.000287	0.000896	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000286	0.000894	CcSEcCtD
Almotriptan—Abdominal pain—Risedronate—osteoporosis	0.000286	0.000894	CcSEcCtD
Almotriptan—Body temperature increased—Risedronate—osteoporosis	0.000286	0.000894	CcSEcCtD
Almotriptan—Rash—Alendronate—osteoporosis	0.000284	0.000888	CcSEcCtD
Almotriptan—Insomnia—Zoledronate—osteoporosis	0.000284	0.000888	CcSEcCtD
Almotriptan—Dermatitis—Alendronate—osteoporosis	0.000284	0.000888	CcSEcCtD
Almotriptan—Feeling abnormal—Pamidronate—osteoporosis	0.000284	0.000886	CcSEcCtD
Almotriptan—Headache—Alendronate—osteoporosis	0.000283	0.000883	CcSEcCtD
Almotriptan—Paraesthesia—Zoledronate—osteoporosis	0.000282	0.000881	CcSEcCtD
Almotriptan—Vomiting—Raloxifene—osteoporosis	0.000282	0.000881	CcSEcCtD
Almotriptan—Gastrointestinal pain—Pamidronate—osteoporosis	0.000281	0.000879	CcSEcCtD
Almotriptan—Dyspnoea—Zoledronate—osteoporosis	0.00028	0.000875	CcSEcCtD
Almotriptan—Rash—Raloxifene—osteoporosis	0.00028	0.000874	CcSEcCtD
Almotriptan—Dermatitis—Raloxifene—osteoporosis	0.000279	0.000873	CcSEcCtD
Almotriptan—Somnolence—Zoledronate—osteoporosis	0.000279	0.000873	CcSEcCtD
Almotriptan—Vomiting—Ibandronate—osteoporosis	0.000279	0.000872	CcSEcCtD
Almotriptan—Tremor—Estradiol—osteoporosis	0.000278	0.000868	CcSEcCtD
Almotriptan—Headache—Raloxifene—osteoporosis	0.000278	0.000868	CcSEcCtD
Almotriptan—Rash—Ibandronate—osteoporosis	0.000277	0.000865	CcSEcCtD
Almotriptan—Dermatitis—Ibandronate—osteoporosis	0.000277	0.000864	CcSEcCtD
Almotriptan—Dyspepsia—Zoledronate—osteoporosis	0.000277	0.000864	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000276	0.000861	CcSEcCtD
Almotriptan—Ill-defined disorder—Estradiol—osteoporosis	0.000275	0.00086	CcSEcCtD
Almotriptan—Headache—Ibandronate—osteoporosis	0.000275	0.000859	CcSEcCtD
Almotriptan—Insomnia—Conjugated Estrogens—osteoporosis	0.000274	0.000855	CcSEcCtD
Almotriptan—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000273	0.000854	CcSEcCtD
Almotriptan—Vomiting—Calcitriol—osteoporosis	0.000273	0.000854	CcSEcCtD
Almotriptan—Agitation—Estradiol—osteoporosis	0.000273	0.000852	CcSEcCtD
Almotriptan—Nausea—Estropipate—osteoporosis	0.000272	0.00085	CcSEcCtD
Almotriptan—Body temperature increased—Pamidronate—osteoporosis	0.000272	0.00085	CcSEcCtD
Almotriptan—Abdominal pain—Pamidronate—osteoporosis	0.000272	0.00085	CcSEcCtD
Almotriptan—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000272	0.000849	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000271	0.000847	CcSEcCtD
Almotriptan—Angioedema—Estradiol—osteoporosis	0.000271	0.000847	CcSEcCtD
Almotriptan—Rash—Calcitriol—osteoporosis	0.000271	0.000847	CcSEcCtD
Almotriptan—Fatigue—Zoledronate—osteoporosis	0.000271	0.000846	CcSEcCtD
Almotriptan—Dermatitis—Calcitriol—osteoporosis	0.000271	0.000846	CcSEcCtD
Almotriptan—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00027	0.000843	CcSEcCtD
Almotriptan—Headache—Calcitriol—osteoporosis	0.000269	0.000841	CcSEcCtD
Almotriptan—Somnolence—Conjugated Estrogens—osteoporosis	0.000269	0.00084	CcSEcCtD
Almotriptan—Pain—Zoledronate—osteoporosis	0.000269	0.000839	CcSEcCtD
Almotriptan—Nausea—Alendronate—osteoporosis	0.000268	0.000837	CcSEcCtD
Almotriptan—Malaise—Estradiol—osteoporosis	0.000268	0.000836	CcSEcCtD
Almotriptan—Hypersensitivity—Risedronate—osteoporosis	0.000267	0.000833	CcSEcCtD
Almotriptan—Vertigo—Estradiol—osteoporosis	0.000267	0.000833	CcSEcCtD
Almotriptan—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000266	0.000832	CcSEcCtD
Almotriptan—Asthenia—Ethinyl Estradiol—osteoporosis	0.000266	0.000832	CcSEcCtD
Almotriptan—Syncope—Estradiol—osteoporosis	0.000266	0.000831	CcSEcCtD
Almotriptan—Nausea—Raloxifene—osteoporosis	0.000263	0.000823	CcSEcCtD
Almotriptan—Pruritus—Ethinyl Estradiol—osteoporosis	0.000263	0.00082	CcSEcCtD
Almotriptan—Palpitations—Estradiol—osteoporosis	0.000262	0.000819	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000261	0.000816	CcSEcCtD
Almotriptan—Fatigue—Conjugated Estrogens—osteoporosis	0.000261	0.000815	CcSEcCtD
Almotriptan—Nausea—Ibandronate—osteoporosis	0.000261	0.000815	CcSEcCtD
Almotriptan—Loss of consciousness—Estradiol—osteoporosis	0.000261	0.000815	CcSEcCtD
Almotriptan—Asthenia—Risedronate—osteoporosis	0.00026	0.000811	CcSEcCtD
Almotriptan—Feeling abnormal—Zoledronate—osteoporosis	0.000259	0.000809	CcSEcCtD
Almotriptan—Pain—Conjugated Estrogens—osteoporosis	0.000259	0.000808	CcSEcCtD
Almotriptan—Gastrointestinal pain—Zoledronate—osteoporosis	0.000257	0.000803	CcSEcCtD
Almotriptan—Hypertension—Estradiol—osteoporosis	0.000256	0.0008	CcSEcCtD
Almotriptan—Pruritus—Risedronate—osteoporosis	0.000256	0.0008	CcSEcCtD
Almotriptan—Nausea—Calcitriol—osteoporosis	0.000255	0.000798	CcSEcCtD
Almotriptan—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000254	0.000793	CcSEcCtD
Almotriptan—Hypersensitivity—Pamidronate—osteoporosis	0.000253	0.000792	CcSEcCtD
Almotriptan—Arthralgia—Estradiol—osteoporosis	0.000253	0.000789	CcSEcCtD
Almotriptan—Myalgia—Estradiol—osteoporosis	0.000253	0.000789	CcSEcCtD
Almotriptan—Chest pain—Estradiol—osteoporosis	0.000253	0.000789	CcSEcCtD
Almotriptan—Anxiety—Estradiol—osteoporosis	0.000252	0.000786	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000251	0.000784	CcSEcCtD
Almotriptan—Discomfort—Estradiol—osteoporosis	0.00025	0.00078	CcSEcCtD
Almotriptan—Body temperature increased—Zoledronate—osteoporosis	0.000248	0.000776	CcSEcCtD
Almotriptan—Abdominal pain—Zoledronate—osteoporosis	0.000248	0.000776	CcSEcCtD
Almotriptan—Diarrhoea—Risedronate—osteoporosis	0.000248	0.000773	CcSEcCtD
Almotriptan—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000247	0.000773	CcSEcCtD
Almotriptan—Dry mouth—Estradiol—osteoporosis	0.000247	0.000772	CcSEcCtD
Almotriptan—Asthenia—Pamidronate—osteoporosis	0.000247	0.000771	CcSEcCtD
Almotriptan—Dizziness—Ethinyl Estradiol—osteoporosis	0.000245	0.000767	CcSEcCtD
Almotriptan—Confusional state—Estradiol—osteoporosis	0.000244	0.000763	CcSEcCtD
Almotriptan—Pruritus—Pamidronate—osteoporosis	0.000243	0.00076	CcSEcCtD
Almotriptan—Anaphylactic shock—Estradiol—osteoporosis	0.000242	0.000756	CcSEcCtD
Almotriptan—Dizziness—Risedronate—osteoporosis	0.000239	0.000748	CcSEcCtD
Almotriptan—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000239	0.000747	CcSEcCtD
Almotriptan—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000239	0.000747	CcSEcCtD
Almotriptan—Shock—Estradiol—osteoporosis	0.000238	0.000744	CcSEcCtD
Almotriptan—Nervous system disorder—Estradiol—osteoporosis	0.000238	0.000742	CcSEcCtD
Almotriptan—Tachycardia—Estradiol—osteoporosis	0.000236	0.000738	CcSEcCtD
Almotriptan—Vomiting—Ethinyl Estradiol—osteoporosis	0.000236	0.000737	CcSEcCtD
Almotriptan—Diarrhoea—Pamidronate—osteoporosis	0.000235	0.000735	CcSEcCtD
Almotriptan—Skin disorder—Estradiol—osteoporosis	0.000235	0.000735	CcSEcCtD
Almotriptan—Hyperhidrosis—Estradiol—osteoporosis	0.000234	0.000731	CcSEcCtD
Almotriptan—Rash—Ethinyl Estradiol—osteoporosis	0.000234	0.000731	CcSEcCtD
Almotriptan—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000234	0.00073	CcSEcCtD
Almotriptan—Headache—Ethinyl Estradiol—osteoporosis	0.000233	0.000726	CcSEcCtD
Almotriptan—Hypersensitivity—Zoledronate—osteoporosis	0.000232	0.000723	CcSEcCtD
Almotriptan—Vomiting—Risedronate—osteoporosis	0.00023	0.000719	CcSEcCtD
Almotriptan—Rash—Risedronate—osteoporosis	0.000228	0.000713	CcSEcCtD
Almotriptan—Dermatitis—Risedronate—osteoporosis	0.000228	0.000712	CcSEcCtD
Almotriptan—Dizziness—Pamidronate—osteoporosis	0.000228	0.000711	CcSEcCtD
Almotriptan—Headache—Risedronate—osteoporosis	0.000227	0.000708	CcSEcCtD
Almotriptan—Asthenia—Zoledronate—osteoporosis	0.000225	0.000704	CcSEcCtD
Almotriptan—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000223	0.000696	CcSEcCtD
Almotriptan—Pruritus—Zoledronate—osteoporosis	0.000222	0.000694	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000221	0.000689	CcSEcCtD
Almotriptan—Nausea—Ethinyl Estradiol—osteoporosis	0.00022	0.000689	CcSEcCtD
Almotriptan—Insomnia—Estradiol—osteoporosis	0.000219	0.000684	CcSEcCtD
Almotriptan—Vomiting—Pamidronate—osteoporosis	0.000219	0.000683	CcSEcCtD
Almotriptan—Paraesthesia—Estradiol—osteoporosis	0.000217	0.000679	CcSEcCtD
Almotriptan—Asthenia—Conjugated Estrogens—osteoporosis	0.000217	0.000678	CcSEcCtD
Almotriptan—Rash—Pamidronate—osteoporosis	0.000217	0.000678	CcSEcCtD
Almotriptan—Dermatitis—Pamidronate—osteoporosis	0.000217	0.000677	CcSEcCtD
Almotriptan—Dyspnoea—Estradiol—osteoporosis	0.000216	0.000674	CcSEcCtD
Almotriptan—Headache—Pamidronate—osteoporosis	0.000216	0.000673	CcSEcCtD
Almotriptan—Somnolence—Estradiol—osteoporosis	0.000215	0.000673	CcSEcCtD
Almotriptan—Diarrhoea—Zoledronate—osteoporosis	0.000215	0.000672	CcSEcCtD
Almotriptan—Nausea—Risedronate—osteoporosis	0.000215	0.000671	CcSEcCtD
Almotriptan—Pruritus—Conjugated Estrogens—osteoporosis	0.000214	0.000669	CcSEcCtD
Almotriptan—Dyspepsia—Estradiol—osteoporosis	0.000213	0.000666	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Estradiol—osteoporosis	0.000209	0.000653	CcSEcCtD
Almotriptan—Fatigue—Estradiol—osteoporosis	0.000209	0.000652	CcSEcCtD
Almotriptan—Dizziness—Zoledronate—osteoporosis	0.000208	0.000649	CcSEcCtD
Almotriptan—Pain—Estradiol—osteoporosis	0.000207	0.000647	CcSEcCtD
Almotriptan—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000207	0.000647	CcSEcCtD
Almotriptan—Nausea—Pamidronate—osteoporosis	0.000204	0.000638	CcSEcCtD
Almotriptan—Dizziness—Conjugated Estrogens—osteoporosis	0.0002	0.000625	CcSEcCtD
Almotriptan—Vomiting—Zoledronate—osteoporosis	0.0002	0.000624	CcSEcCtD
Almotriptan—Feeling abnormal—Estradiol—osteoporosis	0.0002	0.000623	CcSEcCtD
Almotriptan—Rash—Zoledronate—osteoporosis	0.000198	0.000619	CcSEcCtD
Almotriptan—Gastrointestinal pain—Estradiol—osteoporosis	0.000198	0.000619	CcSEcCtD
Almotriptan—Dermatitis—Zoledronate—osteoporosis	0.000198	0.000618	CcSEcCtD
Almotriptan—Headache—Zoledronate—osteoporosis	0.000197	0.000615	CcSEcCtD
Almotriptan—Vomiting—Conjugated Estrogens—osteoporosis	0.000192	0.000601	CcSEcCtD
Almotriptan—Abdominal pain—Estradiol—osteoporosis	0.000191	0.000598	CcSEcCtD
Almotriptan—Body temperature increased—Estradiol—osteoporosis	0.000191	0.000598	CcSEcCtD
Almotriptan—Rash—Conjugated Estrogens—osteoporosis	0.000191	0.000596	CcSEcCtD
Almotriptan—Dermatitis—Conjugated Estrogens—osteoporosis	0.000191	0.000595	CcSEcCtD
Almotriptan—Headache—Conjugated Estrogens—osteoporosis	0.00019	0.000592	CcSEcCtD
Almotriptan—Nausea—Zoledronate—osteoporosis	0.000187	0.000583	CcSEcCtD
Almotriptan—Nausea—Conjugated Estrogens—osteoporosis	0.00018	0.000561	CcSEcCtD
Almotriptan—Hypersensitivity—Estradiol—osteoporosis	0.000178	0.000557	CcSEcCtD
Almotriptan—Asthenia—Estradiol—osteoporosis	0.000174	0.000543	CcSEcCtD
Almotriptan—Pruritus—Estradiol—osteoporosis	0.000171	0.000535	CcSEcCtD
Almotriptan—Diarrhoea—Estradiol—osteoporosis	0.000166	0.000518	CcSEcCtD
Almotriptan—Dizziness—Estradiol—osteoporosis	0.00016	0.0005	CcSEcCtD
Almotriptan—Vomiting—Estradiol—osteoporosis	0.000154	0.000481	CcSEcCtD
Almotriptan—Rash—Estradiol—osteoporosis	0.000153	0.000477	CcSEcCtD
Almotriptan—Dermatitis—Estradiol—osteoporosis	0.000153	0.000477	CcSEcCtD
Almotriptan—Headache—Estradiol—osteoporosis	0.000152	0.000474	CcSEcCtD
Almotriptan—Nausea—Estradiol—osteoporosis	0.000144	0.000449	CcSEcCtD
Almotriptan—HTR1D—GPCR ligand binding—POMC—osteoporosis	3.85e-05	0.00113	CbGpPWpGaD
Almotriptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.83e-05	0.00113	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—POMC—osteoporosis	3.79e-05	0.00112	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CALCA—osteoporosis	3.77e-05	0.00111	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ACP5—osteoporosis	3.77e-05	0.00111	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—POMC—osteoporosis	3.77e-05	0.00111	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CALCA—osteoporosis	3.69e-05	0.00109	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TLN1—osteoporosis	3.64e-05	0.00107	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PNP—osteoporosis	3.59e-05	0.00106	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ATIC—osteoporosis	3.59e-05	0.00106	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PKM—osteoporosis	3.58e-05	0.00105	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—FDPS—osteoporosis	3.58e-05	0.00105	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TLN1—osteoporosis	3.57e-05	0.00105	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—TPI1—osteoporosis	3.5e-05	0.00103	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.5e-05	0.00103	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—ADCY5—osteoporosis	3.48e-05	0.00103	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GPX1—osteoporosis	3.47e-05	0.00102	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GPD2—osteoporosis	3.39e-05	0.001	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PGLS—osteoporosis	3.39e-05	0.001	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.39e-05	0.000999	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—POMC—osteoporosis	3.39e-05	0.000998	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—IL6—osteoporosis	3.36e-05	0.000991	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.34e-05	0.000985	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—P4HB—osteoporosis	3.29e-05	0.000971	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GAPDH—osteoporosis	3.23e-05	0.000953	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.21e-05	0.000946	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—MTHFR—osteoporosis	3.2e-05	0.000944	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—FDPS—osteoporosis	3.19e-05	0.000942	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PKM—osteoporosis	3.19e-05	0.000942	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—RAP1A—osteoporosis	3.15e-05	0.000929	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—P4HB—osteoporosis	3.14e-05	0.000926	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—POMC—osteoporosis	3.11e-05	0.000918	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PNP—osteoporosis	3.1e-05	0.000915	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ATIC—osteoporosis	3.1e-05	0.000915	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—P4HB—osteoporosis	3.07e-05	0.000906	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTH—osteoporosis	3.05e-05	0.0009	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—OXCT1—osteoporosis	3.05e-05	0.0009	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CA2—osteoporosis	3.05e-05	0.0009	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GPD2—osteoporosis	3.03e-05	0.000893	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PGLS—osteoporosis	3.03e-05	0.000893	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RAP1A—osteoporosis	3e-05	0.000885	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTH—osteoporosis	2.99e-05	0.000882	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CNR2—osteoporosis	2.98e-05	0.000878	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MGLL—osteoporosis	2.97e-05	0.000877	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—ADCY5—osteoporosis	2.95e-05	0.000871	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RAP1A—osteoporosis	2.94e-05	0.000867	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—FDPS—osteoporosis	2.94e-05	0.000866	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PKM—osteoporosis	2.94e-05	0.000866	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NFATC1—osteoporosis	2.93e-05	0.000863	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CNR2—osteoporosis	2.91e-05	0.000859	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—DKK1—osteoporosis	2.9e-05	0.000857	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—ADCY5—osteoporosis	2.89e-05	0.000853	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NFATC1—osteoporosis	2.87e-05	0.000845	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—DKK1—osteoporosis	2.84e-05	0.000839	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—WNT1—osteoporosis	2.8e-05	0.000825	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PGLS—osteoporosis	2.78e-05	0.000821	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GPD2—osteoporosis	2.78e-05	0.000821	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ATIC—osteoporosis	2.77e-05	0.000816	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PNP—osteoporosis	2.77e-05	0.000816	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—WNT1—osteoporosis	2.74e-05	0.000808	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.73e-05	0.000804	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—FGA—osteoporosis	2.72e-05	0.000803	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—ADCY5—osteoporosis	2.68e-05	0.000791	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—FGA—osteoporosis	2.67e-05	0.000786	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—POMC—osteoporosis	2.64e-05	0.000778	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CA2—osteoporosis	2.64e-05	0.000778	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—OXCT1—osteoporosis	2.64e-05	0.000778	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—ADCY5—osteoporosis	2.63e-05	0.000775	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MGLL—osteoporosis	2.57e-05	0.000758	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—POMC—osteoporosis	2.56e-05	0.000755	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PNP—osteoporosis	2.55e-05	0.000751	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ATIC—osteoporosis	2.55e-05	0.000751	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ENO1—osteoporosis	2.55e-05	0.000751	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTHLH—osteoporosis	2.53e-05	0.000746	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—BMP2—osteoporosis	2.53e-05	0.000746	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—IDH2—osteoporosis	2.53e-05	0.000745	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PSMA2—osteoporosis	2.51e-05	0.00074	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PSMA5—osteoporosis	2.51e-05	0.00074	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—FDPS—osteoporosis	2.49e-05	0.000734	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PKM—osteoporosis	2.49e-05	0.000734	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTHLH—osteoporosis	2.48e-05	0.000731	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—BMP2—osteoporosis	2.48e-05	0.000731	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—FGB—osteoporosis	2.48e-05	0.00073	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—FGB—osteoporosis	2.42e-05	0.000715	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.42e-05	0.000715	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PSMA2—osteoporosis	2.39e-05	0.000705	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PSMA5—osteoporosis	2.39e-05	0.000705	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP27A1—osteoporosis	2.38e-05	0.000701	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PGLS—osteoporosis	2.36e-05	0.000695	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GPD2—osteoporosis	2.36e-05	0.000695	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—OXCT1—osteoporosis	2.35e-05	0.000694	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CA2—osteoporosis	2.35e-05	0.000694	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PSMA2—osteoporosis	2.34e-05	0.00069	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PSMA5—osteoporosis	2.34e-05	0.00069	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ACP5—osteoporosis	2.31e-05	0.000682	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MGLL—osteoporosis	2.29e-05	0.000676	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CALCA—osteoporosis	2.23e-05	0.000657	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—IDH2—osteoporosis	2.19e-05	0.000644	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CALCA—osteoporosis	2.18e-05	0.000643	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—POMC—osteoporosis	2.17e-05	0.000641	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—OXCT1—osteoporosis	2.17e-05	0.000638	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CA2—osteoporosis	2.17e-05	0.000638	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.16e-05	0.000638	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PNP—osteoporosis	2.16e-05	0.000636	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ATIC—osteoporosis	2.16e-05	0.000636	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—TPI1—osteoporosis	2.15e-05	0.000634	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—POMC—osteoporosis	2.13e-05	0.000627	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MGLL—osteoporosis	2.11e-05	0.000622	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.05e-05	0.000606	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—POMC—osteoporosis	2.04e-05	0.0006	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP19A1—osteoporosis	2.04e-05	0.0006	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KL—osteoporosis	2.02e-05	0.000597	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—P4HB—osteoporosis	2.02e-05	0.000596	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ACP5—osteoporosis	2e-05	0.000589	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GAPDH—osteoporosis	1.98e-05	0.000585	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KL—osteoporosis	1.98e-05	0.000584	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.97e-05	0.000582	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—POMC—osteoporosis	1.97e-05	0.000582	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—IDH2—osteoporosis	1.95e-05	0.000575	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—RAP1A—osteoporosis	1.93e-05	0.00057	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—POMC—osteoporosis	1.93e-05	0.00057	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6R—osteoporosis	1.92e-05	0.000568	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PKM—osteoporosis	1.92e-05	0.000566	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—FDPS—osteoporosis	1.92e-05	0.000566	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6R—osteoporosis	1.88e-05	0.000556	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TPI1—osteoporosis	1.86e-05	0.000548	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—OXCT1—osteoporosis	1.83e-05	0.000541	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CA2—osteoporosis	1.83e-05	0.000541	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.83e-05	0.000541	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PGLS—osteoporosis	1.82e-05	0.000537	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GPD2—osteoporosis	1.82e-05	0.000537	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—IDH2—osteoporosis	1.79e-05	0.000529	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MGLL—osteoporosis	1.79e-05	0.000527	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ACP5—osteoporosis	1.78e-05	0.000526	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.76e-05	0.000519	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—P4HB—osteoporosis	1.75e-05	0.000515	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GAPDH—osteoporosis	1.71e-05	0.000506	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.69e-05	0.000497	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.69e-05	0.000497	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—RAP1A—osteoporosis	1.67e-05	0.000492	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PNP—osteoporosis	1.66e-05	0.000491	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ATIC—osteoporosis	1.66e-05	0.000491	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ADCY5—osteoporosis	1.66e-05	0.00049	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TPI1—osteoporosis	1.66e-05	0.000489	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GPX1—osteoporosis	1.66e-05	0.000489	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ACP5—osteoporosis	1.64e-05	0.000484	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ADCY5—osteoporosis	1.58e-05	0.000467	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ENO1—osteoporosis	1.56e-05	0.000461	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—P4HB—osteoporosis	1.56e-05	0.00046	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ADCY5—osteoporosis	1.55e-05	0.000458	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PSMA2—osteoporosis	1.54e-05	0.000454	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PSMA5—osteoporosis	1.54e-05	0.000454	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SPP1—osteoporosis	1.53e-05	0.000452	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GAPDH—osteoporosis	1.53e-05	0.000451	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—MTHFR—osteoporosis	1.53e-05	0.000451	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TPI1—osteoporosis	1.53e-05	0.00045	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—IDH2—osteoporosis	1.52e-05	0.000448	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SPP1—osteoporosis	1.5e-05	0.000443	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—RAP1A—osteoporosis	1.49e-05	0.00044	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.46e-05	0.000429	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—P4HB—osteoporosis	1.43e-05	0.000423	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.43e-05	0.000421	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CA2—osteoporosis	1.42e-05	0.000417	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—OXCT1—osteoporosis	1.42e-05	0.000417	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GAPDH—osteoporosis	1.41e-05	0.000415	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ACP5—osteoporosis	1.39e-05	0.00041	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IRS2—osteoporosis	1.39e-05	0.000409	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MGLL—osteoporosis	1.38e-05	0.000407	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.37e-05	0.000405	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—RAP1A—osteoporosis	1.37e-05	0.000404	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IRS2—osteoporosis	1.36e-05	0.0004	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—LEP—osteoporosis	1.36e-05	0.0004	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ENO1—osteoporosis	1.35e-05	0.000398	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PSMA5—osteoporosis	1.33e-05	0.000392	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PSMA2—osteoporosis	1.33e-05	0.000392	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—LEP—osteoporosis	1.33e-05	0.000392	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.3e-05	0.000383	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ESR1—osteoporosis	1.3e-05	0.000382	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TPI1—osteoporosis	1.29e-05	0.000381	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.27e-05	0.000374	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.25e-05	0.000368	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—POMC—osteoporosis	1.22e-05	0.000361	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—P4HB—osteoporosis	1.22e-05	0.000358	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.21e-05	0.000357	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ENO1—osteoporosis	1.21e-05	0.000355	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GAPDH—osteoporosis	1.19e-05	0.000352	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PSMA2—osteoporosis	1.19e-05	0.00035	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PSMA5—osteoporosis	1.19e-05	0.00035	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.19e-05	0.000349	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—IDH2—osteoporosis	1.17e-05	0.000346	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—POMC—osteoporosis	1.17e-05	0.000344	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—RAP1A—osteoporosis	1.16e-05	0.000343	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—POMC—osteoporosis	1.14e-05	0.000337	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.14e-05	0.000335	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.12e-05	0.000331	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.11e-05	0.000328	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ENO1—osteoporosis	1.11e-05	0.000327	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.1e-05	0.000325	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.1e-05	0.000324	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PSMA5—osteoporosis	1.09e-05	0.000322	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PSMA2—osteoporosis	1.09e-05	0.000322	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.08e-05	0.000318	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ACP5—osteoporosis	1.07e-05	0.000316	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ADCY5—osteoporosis	1.02e-05	0.000301	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GPX1—osteoporosis	1.02e-05	0.0003	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.01e-05	0.000299	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TPI1—osteoporosis	9.97e-06	0.000294	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP19A1—osteoporosis	9.63e-06	0.000284	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ENO1—osteoporosis	9.39e-06	0.000277	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—osteoporosis	9.38e-06	0.000277	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—P4HB—osteoporosis	9.38e-06	0.000277	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PSMA5—osteoporosis	9.25e-06	0.000273	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PSMA2—osteoporosis	9.25e-06	0.000273	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GAPDH—osteoporosis	9.2e-06	0.000271	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—RAP1A—osteoporosis	8.97e-06	0.000264	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.86e-06	0.000261	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ADCY5—osteoporosis	8.82e-06	0.00026	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GPX1—osteoporosis	8.79e-06	0.000259	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—osteoporosis	8.57e-06	0.000253	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—osteoporosis	8.4e-06	0.000248	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—osteoporosis	8.11e-06	0.000239	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ADCY5—osteoporosis	7.87e-06	0.000232	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GPX1—osteoporosis	7.84e-06	0.000231	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP19A1—osteoporosis	7.51e-06	0.000221	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—POMC—osteoporosis	7.5e-06	0.000221	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ENO1—osteoporosis	7.25e-06	0.000214	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ADCY5—osteoporosis	7.24e-06	0.000213	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—osteoporosis	7.24e-06	0.000213	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GPX1—osteoporosis	7.22e-06	0.000213	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PSMA5—osteoporosis	7.14e-06	0.000211	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PSMA2—osteoporosis	7.14e-06	0.000211	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MYC—osteoporosis	6.74e-06	0.000199	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFB1—osteoporosis	6.72e-06	0.000198	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—osteoporosis	6.66e-06	0.000196	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MYC—osteoporosis	6.6e-06	0.000195	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFB1—osteoporosis	6.58e-06	0.000194	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—POMC—osteoporosis	6.49e-06	0.000191	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ADCY5—osteoporosis	6.13e-06	0.000181	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GPX1—osteoporosis	6.11e-06	0.00018	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.79e-06	0.000171	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—POMC—osteoporosis	5.79e-06	0.000171	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—osteoporosis	5.64e-06	0.000166	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—POMC—osteoporosis	5.33e-06	0.000157	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—osteoporosis	5.07e-06	0.000149	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—osteoporosis	4.96e-06	0.000146	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ADCY5—osteoporosis	4.73e-06	0.00014	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GPX1—osteoporosis	4.72e-06	0.000139	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—POMC—osteoporosis	4.51e-06	0.000133	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—osteoporosis	4.35e-06	0.000128	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—POMC—osteoporosis	3.48e-06	0.000103	CbGpPWpGaD
